Diabetes
This page brings together the European Medicines Agency's (EMA) latest information on diabetes.
It lists the following:
- the newest and most recently updated medicines authorised for diabetes in the European Union
- EMA's latest diabetes-related news announcements
- EMA's upcoming events on diabetes-related topics
We are currently unable to display the new and recently updated medicines authorised for diabetes due to a technical error. We are working to resolve the issue as soon as possible. We apologise for any inconvenience caused.
Latest news
PRAC elects new chair
GLP-1 receptor agonists: available evidence not supporting link with suicidal and self-injurious thoughts and actions
PRAC recommends measures to minimise the risk of serious side effects with medicines containing pseudoephedrine.
EMA’s human medicines committee (CHMP) recommended eight medicines.
Events of interest
Currently, we have no events for this therapeutic area.